PT
Pinteon Therapeutics, Inc.
SEC filingBiotechnology · Newton Centre, MA
Amount raised$29.2Msold at filing
Total offering$32.1M$2.9M still open
Investors in the raise2count reported to the SEC
FiledNov 12, 2025first sale Jan 7, 2022
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Westley R. NolinDirector
Jason R. DingesExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.